Annual Revenue
$245.32 M
+$39.69 M+19.30%
31 December 2023
Summary:
Pharming Group NV annual revenue is currently $245.32 million, with the most recent change of +$39.69 million (+19.30%) on 31 December 2023. During the last 3 years, it has risen by +$33.14 million (+15.62%). PHAR annual revenue is now at all-time high.PHAR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$74.85 M
+$756.00 K+1.02%
30 September 2024
Summary:
Pharming Group NV quarterly revenue is currently $74.85 million, with the most recent change of +$756.00 thousand (+1.02%) on 30 September 2024. Over the past year, it has increased by +$8.19 million (+12.28%). PHAR quarterly revenue is now -7.84% below its all-time high of $81.22 million, reached on 31 December 2023.PHAR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$285.75 M
+$8.19 M+2.95%
30 September 2024
Summary:
Pharming Group NV TTM revenue is currently $285.75 million, with the most recent change of +$8.19 million (+2.95%) on 30 September 2024. Over the past year, it has increased by +$67.03 million (+30.64%). PHAR TTM revenue is now at all-time high.PHAR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.3% | +12.3% | +30.6% |
| 3 y3 years | +15.6% | +41.6% | +42.8% |
| 5 y5 years | +58.7% | +61.5% | +63.0% |
PHAR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.4% | -7.8% | +76.0% | at high | +43.7% |
| 5 y | 5 years | at high | +58.7% | -7.8% | +76.0% | at high | +63.0% |
| alltime | all time | at high | >+9999.0% | -7.8% | >+9999.0% | at high | >+9999.0% |
Pharming Group NV Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $74.85 M(+1.0%) | $285.75 M(+3.0%) |
| June 2024 | - | $74.09 M(+33.3%) | $277.56 M(+7.4%) |
| Mar 2024 | - | $55.59 M(-31.6%) | $258.36 M(+5.3%) |
| Dec 2023 | $245.32 M(+19.3%) | $81.22 M(+21.8%) | $245.32 M(+12.2%) |
| Sept 2023 | - | $66.66 M(+21.4%) | $218.72 M(+6.0%) |
| June 2023 | - | $54.90 M(+29.0%) | $206.30 M(+2.4%) |
| Mar 2023 | - | $42.54 M(-22.1%) | $201.55 M(-2.0%) |
| Dec 2022 | $205.62 M(+3.4%) | $54.62 M(+0.7%) | $205.62 M(+0.9%) |
| Sept 2022 | - | $54.24 M(+8.2%) | $203.77 M(+0.7%) |
| June 2022 | - | $50.15 M(+7.6%) | $202.40 M(+0.2%) |
| Mar 2022 | - | $46.62 M(-11.7%) | $201.92 M(+1.5%) |
| Dec 2021 | $198.87 M(-6.3%) | $52.77 M(-0.2%) | $198.87 M(-0.6%) |
| Sept 2021 | - | $52.86 M(+6.4%) | $200.11 M(-2.8%) |
| June 2021 | - | $49.67 M(+14.0%) | $205.77 M(+2.2%) |
| Mar 2021 | - | $43.56 M(-19.3%) | $201.37 M(-5.1%) |
| Dec 2020 | $212.17 M(+12.0%) | $54.01 M(-7.7%) | $212.17 M(-0.2%) |
| Sept 2020 | - | $58.52 M(+29.3%) | $212.58 M(+6.1%) |
| June 2020 | - | $45.27 M(-16.7%) | $200.41 M(-1.9%) |
| Mar 2020 | - | $54.37 M(-0.1%) | $204.20 M(+7.8%) |
| Dec 2019 | $189.39 M(+22.5%) | $54.42 M(+17.4%) | $189.39 M(+8.0%) |
| Sept 2019 | - | $46.35 M(-5.5%) | $175.34 M(+0.5%) |
| June 2019 | - | $49.06 M(+24.0%) | $174.45 M(+10.6%) |
| Mar 2019 | - | $39.56 M(-2.0%) | $157.78 M(+2.1%) |
| Dec 2018 | $154.58 M(+43.8%) | $40.37 M(-11.2%) | $154.58 M(-0.3%) |
| Sept 2018 | - | $45.46 M(+40.3%) | $155.11 M(+9.8%) |
| June 2018 | - | $32.39 M(-10.9%) | $141.20 M(+10.9%) |
| Mar 2018 | - | $36.35 M(-11.1%) | $127.35 M(+18.4%) |
| Dec 2017 | $107.52 M(+544.1%) | $40.91 M(+29.7%) | $107.52 M(+46.2%) |
| Sept 2017 | - | $31.55 M(+70.2%) | $73.55 M(+60.3%) |
| June 2017 | - | $18.54 M(+12.2%) | $45.88 M(+49.4%) |
| Mar 2017 | - | $16.52 M(+137.9%) | $30.71 M(+83.9%) |
| Dec 2016 | $16.69 M | $6.94 M(+78.9%) | $16.69 M(+38.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $3.88 M(+15.6%) | $12.04 M(+1.8%) |
| June 2016 | - | $3.36 M(+33.8%) | $11.83 M(-4.7%) |
| Mar 2016 | - | $2.51 M(+9.5%) | $12.42 M(+4.9%) |
| Dec 2015 | $11.84 M(-54.0%) | $2.29 M(-37.6%) | $11.84 M(-61.1%) |
| Sept 2015 | - | $3.67 M(-6.8%) | $30.43 M(+8.0%) |
| June 2015 | - | $3.94 M(+104.6%) | $28.17 M(+9.4%) |
| Mar 2015 | - | $1.93 M(-90.8%) | $25.74 M(-0.1%) |
| Dec 2014 | $25.76 M(+172.6%) | $20.89 M(+1378.7%) | $25.76 M(+310.5%) |
| Sept 2014 | - | $1.41 M(-6.6%) | $6.28 M(-3.9%) |
| June 2014 | - | $1.51 M(-22.5%) | $6.53 M(-39.4%) |
| Mar 2014 | - | $1.95 M(+39.5%) | $10.78 M(+14.1%) |
| Dec 2013 | $9.45 M(-32.7%) | $1.40 M(-16.3%) | $9.45 M(-50.8%) |
| Sept 2013 | - | $1.67 M(-71.0%) | $19.20 M(+5.6%) |
| June 2013 | - | $5.76 M(+829.6%) | $18.18 M(+34.8%) |
| Mar 2013 | - | $619.80 K(-94.4%) | $13.48 M(-3.9%) |
| Dec 2012 | $14.04 M(+261.1%) | $11.15 M(+1606.2%) | $14.04 M(+263.8%) |
| Sept 2012 | - | $653.30 K(-38.6%) | $3.86 M(-8.7%) |
| June 2012 | - | $1.06 M(-9.1%) | $4.22 M(+1.6%) |
| Mar 2012 | - | $1.17 M(+20.8%) | $4.16 M(+7.0%) |
| Dec 2011 | $3.89 M(+410.0%) | $969.60 K(-4.9%) | $3.89 M(+7.5%) |
| Sept 2011 | - | $1.02 M(+1.9%) | $3.62 M(+22.3%) |
| June 2011 | - | $1.00 M(+11.4%) | $2.96 M(+51.1%) |
| Mar 2011 | - | $898.00 K(+28.7%) | $1.96 M(+84.8%) |
| Dec 2010 | $762.10 K(+58.8%) | $698.00 K(+93.3%) | $1.06 M(+1567.9%) |
| Sept 2010 | - | $361.10 K(-221.3%) | $63.50 K(-86.2%) |
| Dec 2009 | $480.00 K(-48.1%) | -$297.60 K(-211.0%) | $458.70 K(-39.3%) |
| Sept 2009 | - | $268.00 K(-23.5%) | $756.30 K(+54.9%) |
| June 2009 | - | $350.30 K(+153.8%) | $488.30 K(+253.8%) |
| Mar 2009 | - | $138.00 K | $138.00 K |
| Dec 2008 | $924.40 K(-8.1%) | - | - |
| Dec 2007 | $1.01 M(+418.6%) | - | - |
| Dec 2006 | $194.00 K(-59.6%) | - | - |
| Dec 2005 | $479.70 K | - | - |
FAQ
- What is Pharming Group NV annual revenue?
- What is the all time high annual revenue for Pharming Group NV?
- What is Pharming Group NV annual revenue year-on-year change?
- What is Pharming Group NV quarterly revenue?
- What is the all time high quarterly revenue for Pharming Group NV?
- What is Pharming Group NV quarterly revenue year-on-year change?
- What is Pharming Group NV TTM revenue?
- What is the all time high TTM revenue for Pharming Group NV?
- What is Pharming Group NV TTM revenue year-on-year change?
What is Pharming Group NV annual revenue?
The current annual revenue of PHAR is $245.32 M
What is the all time high annual revenue for Pharming Group NV?
Pharming Group NV all-time high annual revenue is $245.32 M
What is Pharming Group NV annual revenue year-on-year change?
Over the past year, PHAR annual revenue has changed by +$39.69 M (+19.30%)
What is Pharming Group NV quarterly revenue?
The current quarterly revenue of PHAR is $74.85 M
What is the all time high quarterly revenue for Pharming Group NV?
Pharming Group NV all-time high quarterly revenue is $81.22 M
What is Pharming Group NV quarterly revenue year-on-year change?
Over the past year, PHAR quarterly revenue has changed by +$8.19 M (+12.28%)
What is Pharming Group NV TTM revenue?
The current TTM revenue of PHAR is $285.75 M
What is the all time high TTM revenue for Pharming Group NV?
Pharming Group NV all-time high TTM revenue is $285.75 M
What is Pharming Group NV TTM revenue year-on-year change?
Over the past year, PHAR TTM revenue has changed by +$67.03 M (+30.64%)